Advisories: INH/ Rifapentine 12 week therapy is preferred treatment for latent TB infection per BOP Management of Tuberculosis Clinical Practice Guideline, Isoniazid-Rifapentine
Treatment of Latent TB Infection Addendum, 2014
Rifapentine is not recommended in HIV-infected patients receiving antiretroviral treatment because of potential drug interactions.